Theravance Biopharma Inc
Ownership
Ownership Structure
Who owns Theravance Biopharma Inc (TBPH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 49.8% of the shares are freely tradable; institutional investors hold 99.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Madison Avenue Partners, LP | 18.32 | 9,511,150 | +0.0 | 03/31/2026 |
| Weiss Asset Management LP | 14.36 | 7,457,060 | +0.0 | 03/31/2026 |
| Newtyn Management LLC | 9.33 | 4,841,629 | +12.6 | 03/31/2026 |
| BlackRock Inc | 8.28 | 4,296,290 | +6.1 | 03/31/2026 |
| Irenic Capital Management LP | 5.32 | 2,760,948 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.44 | 1,783,753 | +0.0 | 03/31/2026 |
| State Street Corp | 2.50 | 1,297,323 | +17.7 | 03/31/2026 |
| Acadian Asset Management LLC | 2.46 | 1,276,576 | +31,436.0 | 03/31/2026 |
| Two Sigma Investments LLC | 2.36 | 1,225,587 | -2.6 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.50 | 1,295,682 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Samaha Eli | 10% Owner | 9,167,489 | 155,847,313 $ | Jul 7, 2026 | indirect |
| Winningham Rick E | CHIEF EXECUTIVE OFFICER | 1,611,022 | 27,387,374 $ | Aug 20, 2026 | direct |
| Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | 355,168 | 6,037,856 $ | Aug 20, 2026 | direct |
| Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | 336,841 | 5,726,297 $ | Aug 20, 2026 | direct |
| Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 226,790 | 3,855,430 $ | Aug 20, 2026 | direct |
| Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | 189,826 | 3,227,042 $ | Aug 20, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Other | 6,258 | 16.95 | 106,073 |
| Aug 20, 2026 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Other | 7,952 | 16.95 | 134,786 |
| Aug 20, 2026 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Other | 8,112 | 16.95 | 137,498 |
| Aug 20, 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Other | 5,667 | 16.95 | 96,056 |
| Aug 20, 2026 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Other | 20,034 | 16.95 | 339,576 |
| Jul 7, 2026 | Samaha Eli | 10% Owner | Sell | 5,564 | 17.17 | 95,541 |
| Jul 6, 2026 | Samaha Eli | 10% Owner | Sell | 1,400 | 17.04 | 23,856 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.